PNC Financial Services Group
CRL icon

PNC Financial Services Group’s Charles River Laboratories CRL Stock Holding History

PNC Financial Services Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.34M Buy
14,747
+260
+2% +$46.3K ﹤0.01% 874
2026
Q1 		$2.5M Sell
14,487
-1,571
-10% -$291K ﹤0.01% 925
2025
Q4 		$3.2M Buy
16,058
+301
+2% +$54.6K ﹤0.01% 823
2025
Q3 		$2.47M Sell
15,757
-1,611
-9% -$256K ﹤0.01% 883
2025
Q2 		$2.64M Buy
17,368
+1,442
+9% +$192K ﹤0.01% 851
2025
Q1 		$2.4M Buy
15,926
+1,648
+12% +$276K ﹤0.01% 862
2024
Q4 		$2.64M Buy
14,278
+2,916
+26% +$562K ﹤0.01% 840
2024
Q3 		$2.24M Sell
11,362
-274
-2% -$56.9K ﹤0.01% 883
2024
Q2 		$2.4M Sell
11,636
-106
-0.9% -$24K ﹤0.01% 846
2024
Q1 		$3.18M Buy
11,742
+252
+2% +$60.2K ﹤0.01% 768
2023
Q4 		$2.72M Buy
11,490
+606
+6% +$119K ﹤0.01% 789
2023
Q3 		$2.13M Sell
10,884
-7
-0.1% -$1.44K ﹤0.01% 837
2023
Q2 		$2.29M Sell
10,891
-635
-6% -$126K ﹤0.01% 843
2023
Q1 		$2.33M Sell
11,526
-210
-2% -$47.6K ﹤0.01% 830
2022
Q4 		$2.56M Buy
11,736
+250
+2% +$54.6K ﹤0.01% 803
2022
Q3 		$2.26M Buy
11,486
+113
+1% +$24.4K ﹤0.01% 828
2022
Q2 		$2.43M Buy
11,373
+1,176
+12% +$287K ﹤0.01% 823
2022
Q1 		$2.9M Buy
10,197
+122
+1% +$37.6K ﹤0.01% 824
2021
Q4 		$3.8M Buy
10,075
+5,914
+142% +$2.3M ﹤0.01% 760
2021
Q3 		$1.72M Buy
4,161
+1
+0% +$415 ﹤0.01% 969
2021
Q2 		$1.54M Sell
4,160
-1,568
-27% -$524K ﹤0.01% 1025
2021
Q1 		$1.66M Sell
5,728
-1,178
-17% -$327K ﹤0.01% 958
2020
Q4 		$1.73M Buy
6,906
+235
+4% +$56K ﹤0.01% 892
2020
Q3 		$1.51M Sell
6,671
-1,838
-22% -$381K ﹤0.01% 875
2020
Q2 		$1.48M Buy
8,509
+262
+3% +$41.8K ﹤0.01% 886
2020
Q1 		$1.04M Buy
8,247
+1,801
+28% +$270K ﹤0.01% 953
2019
Q4 		$985K Sell
6,446
-7,259
-53% -$1.01M ﹤0.01% 1100
2019
Q3 		$1.81M Sell
13,705
-7,686
-36% -$1.03M ﹤0.01% 1024
2019
Q2 		$3.04M Sell
21,391
-2,044
-9% -$277K ﹤0.01% 863
2019
Q1 		$3.4M Sell
23,435
-925
-4% -$122K ﹤0.01% 851
2018
Q4 		$2.76M Sell
24,360
-437
-2% -$54.7K ﹤0.01% 887
2018
Q3 		$3.33M Buy
24,797
+2,112
+9% +$261K ﹤0.01% 889
2018
Q2 		$2.55M Sell
22,685
-2,109
-9% -$228K ﹤0.01% 956
2018
Q1 		$2.65M Buy
24,794
+683
+3% +$73.6K ﹤0.01% 935
2017
Q4 		$2.64M Buy
24,111
+1,662
+7% +$181K ﹤0.01% 946
2017
Q3 		$2.43M Sell
22,449
-525
-2% -$53.9K ﹤0.01% 955
2017
Q2 		$2.32M Buy
22,974
+242
+1% +$22.3K ﹤0.01% 949
2017
Q1 		$2.04M Sell
22,732
-61
-0.3% -$5.18K ﹤0.01% 994
2016
Q4 		$1.74M Buy
22,793
+17,179
+306% +$1.3M ﹤0.01% 1055
2016
Q3 		$467K Buy
5,614
+1,827
+48% +$153K ﹤0.01% 1591
2016
Q2 		$312K Buy
3,787
+543
+17% +$44.7K ﹤0.01% 1819
2016
Q1 		$246K Buy
3,244
+2,413
+290% +$179K ﹤0.01% 1966
2015
Q4 		$67K Buy
831
+596
+254% +$43K ﹤0.01% 2682
2015
Q3 		$15K Buy
235
+15
+7% +$1.08K ﹤0.01% 3498
2015
Q2 		$15K Sell
220
-84
-28% -$6.22K ﹤0.01% 3618
2015
Q1 		$24K Buy
304
+207
+213% +$15.3K ﹤0.01% 3417
2014
Q4 		$6K Buy
97
+1
+1% +$63 ﹤0.01% 3489
2014
Q3 		$6K Sell
96
-7
-7% -$401 ﹤0.01% 3401
2014
Q2 		$6K Sell
103
-436
-81% -$23.9K ﹤0.01% 3256
2014
Q1 		$32K Buy
539
+503
+1,397% +$29.3K ﹤0.01% 2673
2013
Q4 		$2K Sell
36
-699
-95% -$35.1K ﹤0.01% 3240
2013
Q3 		$34K Buy
735
+66
+10% +$3.03K ﹤0.01% 2633
2013
Q2 		$27K Buy
+669
New +$28.7K ﹤0.01% 2632

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

PNC Financial Services Group's CRL Position: Q2 2026 in Review

PNC Financial Services Group increased its Charles River Laboratories (CRL) stake by 1.8% in Q2 2026, buying an estimated $46.3K and bringing the position to 14,747 shares worth $3.34M. The position accounts for ﹤0.01% of the portfolio, ranked #874.

PNC Financial Services Group first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.8M in Q4 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • PNC Financial Services Group held 14,747 shares of Charles River Laboratories worth $3.34M as of Q2 2026.
  • PNC Financial Services Group bought 260 Charles River Laboratories shares in Q2 2026, an estimated $46.3K.
  • Charles River Laboratories made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #874 holding.
  • PNC Financial Services Group first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
  • PNC Financial Services Group's Charles River Laboratories position peaked at $3.8M in Q4 2021.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.